Aarhus Universitetshospital; Kræftafdelingen

Aarhus N 8200

0 studies enrolling now · 3 studies all time

What they study most

Renal Cell Carcinoma, Tumors

Studies at this site

• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early
• A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) — Completed
• A Study of Atezolizumab in Advanced Solid Tumors — Completed